They used a specific CRC organoids model harboring ACP, Trp53, Tgfbr2, K-rasG12D(APTK) mutations, similarly to the human mesenchymal CRC subtype (CMS4). The gene discussed is TGFBR2; the disease is colorectal carcinoma.